We recently published a list of 12 Best Stocks to Invest in for a Stock Market Game. In this article, we are going to take a ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Xeris Biopharma (XERS), a fast-growing biopharmaceutical company, beat top and bottom-line expectations for Q4 and announced it is expecting ...

Xeris Biopharma Holdings ... is an industry leading US-based pharmaceutical company. For nearly 60 years, American Regent has been developing, manufacturing and supplying quality generic and ...

CHICAGO - Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a $742 million market cap pharmaceutical company whose stock has surged 116% over the past year, has announced the FDA approval of its ...

XERIS PHARMATICALS ($XERS) posted quarterly earnings results on Thursday, March 6th. The company reported earnings of -$0.03 per share, beating estimates of -$0.06 by ...

Shares of Xeris Biopharma climbed after the company guided for higher revenue in 2025. The stock was up 17%, to $4.41, in Thursday trading, which is equivalent to the highest close since June 28, 2021 ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commerc ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals (XERS – Research Report) and Jupiter Neurosciences, Inc. (JUNS – Research ...

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $5.1 million in its fourth quarter. The Chicago-based company said it had a loss of 3 cents per share ...

Xeris Pharmaceuticals Inc. (XERS), with a market capitalization of $562 million, reported its fourth-quarter 2024 earnings, surpassing expectations with an earnings per share (EPS) of -0.03, compared ...